AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 170 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $24,989,625 | +56.3% | 882,402 | +26.8% | 0.03% | +50.0% |
| Q1 2023 | $15,988,866 | +214199.2% | 696,076 | +162.0% | 0.02% | +81.8% |
| Q4 2022 | $7,461 | -99.9% | 265,718 | +36.1% | 0.01% | +37.5% |
| Q3 2022 | $5,521,000 | +50.0% | 195,221 | +17.6% | 0.01% | +60.0% |
| Q2 2022 | $3,680,000 | +1.7% | 165,972 | +33.5% | 0.01% | +25.0% |
| Q1 2022 | $3,618,000 | +0.2% | 124,286 | +13.2% | 0.00% | 0.0% |
| Q4 2021 | $3,609,000 | -25.5% | 109,810 | +4.6% | 0.00% | -20.0% |
| Q3 2021 | $4,843,000 | – | 104,932 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
| Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
| Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
| Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
| Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
| ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
| Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |